Navigation Links
KineMatik Group Ltd. Appoints Michael G. Jarjour as President & CEO
Date:1/21/2009

Former Organon VP of Global Marketing Will Oversee Life Sciences Software Group

Cork, Ireland (PRWEB) January 21, 2009 - The KineMatik™ Group LTD ("KineMatik"), providers of software solutions for managing scientific R&D knowledge, information and processes, announced that it has appointed Michael G. Jarjour as President & CEO.

Mr. Jarjour, with more than eighteen years of experience in the pharmaceutical research and healthcare technology industries, will lead KineMatik as the company continues to offer leadership and innovation to its pharmaceutical, biotechnology and government clients.

"We are delighted to welcome Michael to the KineMatik team. His extensive experience in sales, marketing, operations and strategic planning, combined with his background and entrepreneurial skills in the life sciences and technology industries, will help us consolidate our position as leaders in the scientific enterprise content of management space," said Harry Lorton, Chairman of the Board of Directors for KineMatik.

"I am pleased to join KineMatik, which has developed an impressive and innovative technology platform," said Mr. Jarjour. "Serving industries so dependent on the rapid, accurate collection of scientific data, KineMatik offers a unique value proposition by supporting secure portfolio, knowledge and project management while lowering costs, increasing productivity and improving time-to-market. In this era of financial and regulatory scrutiny, and intellectual property protection, KineMatik is poised to make a difference in the research and development process."

Before joining KineMatik, Mr. Jarjour was Vice President of Global Marketing for Organon, responsible for leading the $1.5 billion gynecology and urology franchise.

Previously, Mr. Jarjour held key positions at top tier pharmaceutical organizations including Bristol-Myers Squibb, Pharmacia, Warner Lambert and Wyeth. Prior to his work in the pharmaceutical industry, he was the COO and founder of a healthcare technology enterprise for an award-winning, best-in-industry wireless Internet prescribing platform.

Mr. Jarjour holds a BS in Finance from Florida International University and an MBA from the Rutgers University.

About KineMatik: KineMatik brings business methods to the life sciences R&D process, by increasing productivity, accountability and transparency. The company's flagship product, eNovator, is the only software program that lets pharmaceutical, biotechnology and government organizations collaboratively manage their information, knowledge and business processes in one seamlessly integrated and secure system. eNovator, allows researchers to deliver innovation throughout the R&D product development lifecycle. Established in Cork, Ireland in 1999, KineMatik also has offices in London, Princeton, and San Diego. Additional information is available at www.kinematik.com.

Contact:
Jennifer Buchholz
KineMatik
jbuchholz(at)kinematik(dot)com

# # #

Read the full story at http://www.prweb.com/releases/KineMatik_Group/Michael_G_Jarjour/prweb1889204.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. AIM Health Group Inc. and Med-Emerg International Inc. Announce Completion of Previously Disclosed Merger Transaction
2. The Quantum Group Announces Support of Technology Bill Before Congress
3. KJT Group L.L.C. Continues Solid Growth
4. Atlanta Educator Kim Bearden Honored as Healthy Hero by AMERIGROUP Foundation
5. Rochester Medical Announces Settlement With TYCO Healthcare Group, L.P., Now Operating as Covidien Ltd.
6. EBG Advisors and Oldaker Group Form National Health Advisors
7. The Quantum Group and IBM Announce Hosting Agreement for Advanced Healthcare Solutions
8. SOKO Fitness & Spa Group Announces Second Quarter FY2009 Financial Results
9. SOKO Fitness & Spa Group Announces Changes to Previously Issued Financial Statements
10. U.S. and European Advocacy Groups Launch United, Global Campaign to Prevent Cervical Cancer
11. Med-Emerg International Inc. receives court approval for AIM Health Group arrangement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star ... , Millions of individuals in the United States and Canada wear eyeglasses. Once considered ... both correct vision and make a fashion statement. Even celebrities use glasses as a ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified ... be personalized through a fitness app. The fitness app plans to fix the two major ... only offer a one size fits all type program , They don’t eliminate ...
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
Breaking Medicine Technology: